Exercise Program for Breast Cancer Patients During Chemotherapy

All-extremity Exercise During Breast Cancer Chemotherapy

Recruiting N/A Interventional Study
Breast Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 85
Sex
Female
Study type
Interventional
Purpose
Prevention
Participants needed
68 (estimated)
Sponsor
University of Florida · Other
Who this trial is looking for

This trial is looking for women with early-stage breast cancer who are starting chemotherapy. Participants will engage in an exercise program to see if it helps protect their heart health during treatment.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with breast cancer that is not spread to other parts of my body.
  • I am female.
  • I am between 18 and 85 years old.
  • I am scheduled to start chemotherapy soon.
  • I have been approved by the study doctor to participate.
  • I can give my consent to join the study.

You may not be able to join if

  • I am receiving targeted therapies like CDK4/6 or PARP inhibitors.
  • I am getting radiation therapy at the same time as chemotherapy.
  • I have lymphedema stage 2 or higher before enrolling in the study.
  • I have serious heart or blood vessel problems.
  • I am currently involved in other experimental treatments that might affect the study.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

Currently, there are 3.5 million breast cancer survivors in the United States and this number is expected to increase dramatically. The proposed research will examine whether a novel exercise intervention for breast cancer patients who are undergoing chemotherapy protects against cardiovascular dysfunction. Findings may have implications for cardiovascular disease prevention in this population.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Active diagnosis of primary invasive non-metastatic breast cancer, stages I-III * Female * 18 to 85 years of age * Scheduled to initiate neoadjuvant or adjuvant chemotherapy (anthracycline, alkylating agent and/or taxane) * Absence of contraindications to exercise * Study clin…
Contacts

Demetra Christou, PhD

3522941746

ddchristou@ufl.edu

CONTACT

Eileen Handberg

352-273-9082

handbem@medicine.ufl.edu

CONTACT